Acadian Asset Management
ETON icon

Acadian Asset Management’s Eton Pharmaceutcials ETON Stock Holding History

Acadian Asset Management’s Portfolio ETON Stock Details ETON Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-26,410
Closed -$573K – 2007
2025
Q3 		$573K Sell
26,410
-366,305
-93% -$6.08M ﹤0.01% 1185
2025
Q2 		$5.59M Sell
392,715
-9,713
-2% -$154K 0.01% 563
2025
Q1 		$5.22M Buy
402,428
+153,923
+62% +$2.33M 0.01% 490
2024
Q4 		$3.31M Buy
248,505
+142,551
+135% +$1.45M 0.01% 637
2024
Q3 		$634K Sell
105,954
-14,620
-12% -$61.8K ﹤0.01% 1027
2024
Q2 		$395K Sell
120,574
-35,812
-23% -$125K ﹤0.01% 1276
2024
Q1 		$585K Buy
156,386
+18,898
+14% +$82.5K ﹤0.01% 969
2023
Q4 		$601K Buy
137,488
+40,224
+41% +$161K ﹤0.01% 988
2023
Q3 		$403K Buy
+97,264
New +$375K ﹤0.01% 1059

Other funds holding ETON

OM
Opaleye Management Boston, Massachusetts $759M AUM 124.8% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
NPT
National Philanthropic Trust Jenkintown, Pennsylvania $9.38B AUM 33.37% 1-Year Est. Return
WIM
Westside Investment Management Santa Monica, California $761M AUM 39.85% 1-Year Est. Return

Acadian Asset Management's ETON Position: Q4 2025 in Review

Acadian Asset Management sold out of Eton Pharmaceutcials (ETON) in Q4 2025, closing a stake of 26,410 shares — an estimated $573K sold.

Acadian Asset Management first reported a position in ETON in Q3 2023 and held it in 9 quarters. The position peaked at $5.59M in Q2 2025. 104 funds tracked by Wall St. Rank hold ETON as of Q4 2025.

  • Acadian Asset Management reported no remaining Eton Pharmaceutcials position as of Q4 2025 after selling out during the quarter.
  • Acadian Asset Management sold 26,410 Eton Pharmaceutcials shares in Q4 2025, an estimated $573K.
  • Acadian Asset Management first reported a position in Eton Pharmaceutcials in Q3 2023 and held it in 9 quarters.
  • Acadian Asset Management's Eton Pharmaceutcials position peaked at $5.59M in Q2 2025.
  • 104 funds tracked by Wall St. Rank held Eton Pharmaceutcials as of Q4 2025.

Based on Acadian Asset Management's 13F filing for Q4 2025, filed 10 Feb 2026.